Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Filings indexed 1,200 across all filing types
Latest filing 2021-09-06 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is an official communication from Strides Pharma Science Limited to stock exchanges regarding a shareholder's request for a duplicate share certificate due to loss of the original. It references Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which governs share certificate issuance and related disclosures. The content focuses on the procedural update about the issuance of a duplicate share certificate and includes correspondence between the company, registrar, and shareholder. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an announcement related to share certificate issuance, which falls under share capital changes but specifically relates to duplicate share certificates. This type of announcement is best classified under Share Issue/Capital Change (SHA) as it concerns changes in share certificates and related capital documentation rather than a financial report or regulatory filing. The document length and detail support it being a formal announcement rather than a brief notice or certification. Therefore, the appropriate classification is SHA with high confidence.
2021-09-06 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal letter addressed to stock exchanges announcing the allotment of shares under an employee stock option plan (ESOP). It specifies the number of shares allotted, the increase in paid-up share capital, and confirms that the new shares rank equally with existing shares. There is no financial statement or detailed financial analysis present, nor is it a report or presentation. The content clearly relates to a change in the company's capital structure due to share allotment. According to the filing definitions, announcements regarding new share issues or capital changes fall under 'Share Issue/Capital Change' (SHA). The document length is short and focused solely on this capital change, confirming it is not a full report or other filing type.
2021-09-06 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a communication addressed to stock exchanges regarding the outcome of the 30th Annual General Meeting (AGM) of the company. It mentions the passing of resolutions by members through remote e-voting and e-voting at the meeting. The document includes voting results and a scrutinizer's report as annexures. The content focuses on the official results of shareholder votes at the AGM, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not the AGM presentation materials themselves, nor is it a full annual report or financial statement. It is also not a proxy solicitation or a regulatory filing unrelated to voting results. Therefore, the appropriate classification is DVA with high confidence.
2021-09-04 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 30th Annual General Meeting (AGM) of the Company' and details the summary of the AGM held on September 3, 2021. It includes information about the meeting attendees, the agenda items discussed, resolutions passed, and voting procedures. The document does not contain full financial statements or detailed financial analysis but rather a summary of the meeting proceedings. It is not an announcement of the AGM but the actual summary of what transpired during the AGM. Therefore, it fits the category of AGM Information (AGM-R). The document length is 5989 characters, which is sufficient for a detailed summary but not a full annual report or financial report. Hence, the classification is AGM-R with high confidence.
2021-09-03 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding a request for issuance of a duplicate share certificate due to the death of a shareholder. It references Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to share certificate matters. The content is about notifying the exchanges of this procedural request and does not contain financial data, management discussion, or report publication. It is not an annual report, earnings release, or any financial report. It is also not a voting result, board change, or capital update. The document is an official regulatory announcement related to share certificate issuance and procedural compliance. Given the nature and length (3439 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-03 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the grant of stock options under the company's ESOP plan. It details the number of options granted, exercise price, vesting period, and exercisability terms. This is a notification about a share-based compensation event, specifically the granting of stock options to employees. It is not a full report, financial statement, or earnings release. It is also not a regulatory filing about voting, management changes, or legal matters. The content fits best under the category of Share Issue/Capital Change (SHA), as it relates to the issuance of stock options which affect the company's capital structure.
2021-08-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.